Table 2 Elimination of water-soluble substances and bilirubin during the first ADVOS treatment of each patient
| Â | Before ADVOS (mg/dl) | After ADVOS (mg/dl) | Relative elimination for each ADVOS treatment (%) | Rate of treatments showing a reduction of serum levels (%) |
|---|---|---|---|---|
Creatinine (mg/dl) | 1.65 (1.15, 2.36) | 1.13** (0.87, 1.82) | − 24% (− 49%, − 5%) | 69 |
BUN (mg/dl) | 28 (17, 44) | 16** (11, 23) | − 48% (− 62%, − 17%) | 84 |
Ammonia (µmol/l) | 65 (58, 87) | 58** (45, 72) | − 19% (− 60%, − 8%) | 91 |
Bilirubin (mg/dl) | 4.5 (0.9, 19.1) | 4.1** (0.9, 12.6) | − 20% (− 34%, − 4%) | 76 |